Back to companies

Phathom Pharmaceuticals Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Phathom Pharmaceuticals Inc (Phathom Pharmaceuticals) is a biopharmaceutical company that develops and commercializes treatments for gastrointestinal (GI) diseases. It carries out the development of innovative therapeutics for acid-related gastrointestinal (GI) disorders. The company's pipeline products include vonoprazan, an oral small-molecule potassium-competitive acid blocker (P-CAB). Phathom Pharmaceuticals also evaluates its vonoprazan in combination with antibiotics for the treatment of Helicobacter pylori infection. The company operates in the US, and Canada. Phathom Pharmaceuticals is headquartered in Florham Park, New Jersey, the US.

 Gain a 360-degree view of Phathom Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Phathom Pharmaceuticals Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address Suite 102, 100 Campus Drive, Florham Park, New Jersey, 07932
Website www.phathompharma.com
Telephone 1 877 7428466
No of Employees 371
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange PHAT (NASD)
Revenue (2024) $175.1M 216.9% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ 33.8% (2024 vs 2023)
Market Cap* $840.2M
Net Profit Margin (2024) XYZ 79.1% (2024 vs 2023)
* As of and is in US$
View Phathom Pharmaceuticals Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Phathom Pharmaceuticals Inc premium industry data and analytics

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Phathom Pharmaceuticals Inc’s relevant decision makers and contact details.

20+

Catalyst Calendar

Proactively evaluate Phathom Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

12+

Clinical Trials

Determine Phathom Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2

Marketed Drugs

Understand Phathom Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Pipeline Drugs

Identify which of Phathom Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
VOQUEZNA (vonoprazan) TRIPLE PAK: H. Pylori, Infection VOQUEZNA
VOQUEZNA DUAL PAK: H. Pylori, Infection VOQUEZNA TRIPLE PAK
VOQUEZNA (Vonoprazan): Erosive GERD VOQUEZNA DUAL PAK
Understand Phathom Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Phathom Pharmaceuticals Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Phathom Pharmaceuticals Inc Cosmo Pharmaceuticals NV Verrica Pharmaceuticals Inc RedHill Biopharma Ltd Salix Pharmaceuticals Inc
Headquarters United States of America Ireland United States of America Israel United States of America
City Florham Park Dublin West Chester Tel Aviv Bridgewater
State/Province New Jersey - Pennsylvania Tel Aviv New Jersey
No. of Employees 371 325 76 13 -
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Michael F. Cola Chairman Executive Board 2022 66
Steven Basta Chief Executive Officer; President; Director Executive Board 2025 60
Anne Marie Cook Secretary; Chief Legal Officer Senior Management 2025 64
Paul Cocja Chief People Officer Senior Management - -
Bill Aprea Chief Legal Officer - Deputy; Chief Compliance Officer; Senior Vice President Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Phathom Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Phathom Pharmaceuticals Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?